Michael Schotsaert
Overview
Explore the profile of Michael Schotsaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
4441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warang P, Singh G, Moshir M, Binazon O, Laghlali G, Chang L, et al.
Hum Vaccin Immunother
. 2025 Mar;
21(1):2470542.
PMID: 40028815
Antagonism of the neonatal Fc receptor through an engineered antibody Fc fragment, such as efgartigimod, results in a decrease in immunoglobulin G levels. This approach is being evaluated as a...
2.
Noureddine M, Chang L, Chang L, El Ayache F, El-Ayache F, Laghlali G, et al.
Res Sq
. 2025 Feb;
PMID: 39975920
Squalene-based adjuvants like MF59, and its research alternative AddaVax, induce transient muscle injury, but their working mechanisms downstream of muscle injury remain unclear. We show that an AddaVax-adjuvanted quadrivalent inactivated...
3.
Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al.
Nature
. 2025 Feb;
638(8052):E46.
PMID: 39905258
No abstract available.
4.
Mattiuz R, Boumelha J, Hamon P, Le Berichel J, Vaidya A, Soong B, et al.
bioRxiv
. 2025 Jan;
PMID: 39763802
Tertiary lymphoid structures (TLS) are organized immune cell aggregates that arise in chronic inflammatory conditions. In cancer, TLS are associated with better prognosis and enhanced response to immunotherapy, making these...
5.
Vincent R, Rapoport D, Balchandani P, Borrello J, Schotsaert M, Karlicek R, et al.
Sci Rep
. 2024 Dec;
14(1):31799.
PMID: 39738586
Respiratory interventions including noninvasive ventilation, continuous positive airway pressure and high-flow nasal oxygen generated infectious aerosols may increase risk of airborne disease (SARS-CoV-2, influenza virus) transmission to healthcare workers. We...
6.
Slamanig S, Lemus N, Lai T, Mishra M, Abdeljawad A, Boza M, et al.
Vaccine
. 2024 Dec;
45():126586.
PMID: 39667115
The rapid development of coronavirus disease 2019 (COVID-19) vaccines has helped mitigate the initial impact of the pandemic. However, in order to reduce transmission rates and protect more vulnerable and...
7.
Singh G, Diego J, Warang P, Park S, Chang L, Noureddine M, et al.
Nat Commun
. 2024 Nov;
15(1):10178.
PMID: 39580470
Antigenically distinct SARS-CoV-2 variants increase the reinfection risk for vaccinated and previously exposed population due to antibody neutralization escape. COVID-19 severity depends on many variables, including host immune responses, which...
8.
Miller M, Montomoli E, Leshem E, Schotsaert M, Weinke T, Vicic N, et al.
Hum Vaccin Immunother
. 2024 Nov;
20(1):2421096.
PMID: 39552079
Although influenza A viruses predominate globally, influenza B viruses are responsible for a significant and often underappreciated burden. Despite this, immunity to influenza B viruses remains understudied, and there is...
9.
Laghlali G, Wiest M, Karadag D, Warang P, OKonek J, Chang L, et al.
Mol Ther
. 2024 Nov;
32(12):4448-4466.
PMID: 39489918
Current COVID-19 mRNA vaccines delivered intramuscularly (IM) induce effective systemic immunity, but with suboptimal immunity at mucosal sites, limiting their ability to impart sterilizing immunity. There is strong interest in...
10.
Dirvin B, Noh H, Tomassoni L, Cao D, Zhou Y, Ke X, et al.
bioRxiv
. 2024 Oct;
PMID: 39464067
Although the impact of SARS-CoV-2 in the lung has been extensively studied, the molecular regulators and targets of the host-cell programs hijacked by the virus in distinct human airway epithelial...